The startup develops eye-brain interfaced virtual reality headsets that analyze users' emotional states in real-time by measuring physiological signals such as brainwaves, eye movements, and pupil sizes. This technology enables users to engage with content like games and videos while gaining insights into their unspoken emotions.
Funding
$8.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Early detection of cognitive decline is critical for improving the quality of life for the elderly, but traditional methods often lack accessibility and convenience for regular screening. Current cognitive assessments may not effectively capture subtle changes in daily life, hindering timely intervention.
Solution
Looxid Labs offers a VR-based platform, "LUCY," designed for the early detection of cognitive impairment by integrating wearable EEG sensors within a virtual reality headset. The platform collects and analyzes EEG signals during VR-based cognitive tasks, providing biosignal-driven insights into brain function. By simulating daily life scenarios within the VR environment, LUCY aims to identify subtle cognitive changes that may indicate early signs of dementia. The technology facilitates proactive mental healthcare by enabling accessible and convenient cognitive assessments.
Target Audience
The primary target audience includes healthcare providers, researchers, and elderly care facilities focused on early detection and management of cognitive decline in older adults.
Features
- VR-integrated wearable EEG sensors for collecting brainwave data during cognitive tasks.
- Biosignal analysis to detect early signs of cognitive impairment.
- VR-based screening content simulating daily life scenarios.
- AI-powered analysis of EEG signals for objective cognitive assessment.
- Data-driven insights into cognitive function and potential decline.